Verona Pharma plc - American Depositary Shares (NQ:VRNA)

106.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Verona Pharma plc - American Depositary Shares

< Previous 1 2 3 4 5 Next >

The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff

February 06, 2026

The life sciences sector has entered 2026 in the midst of a historic transformation, as deal volume and value surged by a staggering 82% over the past year. This "Great Rebound," fueled by a...

Via MarketMinute

The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs

February 02, 2026

As the pharmaceutical industry enters the heart of its Q4 2025 earnings season this February 2, 2026, a clear divide has emerged between the high-flying giants of the metabolic gold rush and those...

Via MarketMinute

Topics Economy Government Intellectual Property

Looking Into Verona Pharma's Recent Short Interest ↗

August 20, 2025

Via Benzinga

Is the Market Bullish or Bearish on Verona Pharma? ↗

July 18, 2025

Via Benzinga

Is Verona Pharma Gaining or Losing Market Support? ↗

June 25, 2025

Via Benzinga

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82% ↗

December 30, 2025

STAAR’s results show a story about timing, cash discipline, and what happens when reported growth finally lines up with underlying demand.

Via The Motley Fool

Topics Regulatory Compliance

FNY Investment Advisers Initiated a New Position in Sibanye Stillwater. Is the Stock a Buy? ↗

December 17, 2025

This global miner extracts gold and platinum group metals, leveraging integrated operations and recycling across multiple continents.

Via The Motley Fool

Topics Regulatory Compliance

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗

November 13, 2025

Via Stocktwits

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025....

Via MarketMinute

Topics Intellectual Property

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today ↗

July 31, 2025

These stocks have all surged more than 1,000% since August 2020.

Via The Motley Fool

Topics Artificial Intelligence

Does This Move Make Merck Stock a Buy? ↗

July 20, 2025

Via The Motley Fool

Topics Intellectual Property

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business ↗

July 17, 2025

Via The Motley Fool

Topics Intellectual Property

The trading volume of these stocks is deviating from the norm in today's session. ↗

July 16, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

July 14, 2025

Via Benzinga

Nvidia's $4 Trillion Milestone Lifts Wall Street: What's Moving Markets Wednesday? ↗

July 09, 2025

Wall Street rose on Wednesday as investors shrugged off fresh trade uncertainty after the White House delayed the start of new tariffs to Aug. 1, raising hopes for new rounds of negotiations.

Via Benzinga

Topics World Trade

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

Which stocks are gapping on Wednesday? ↗

July 09, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug ↗

July 09, 2025

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.

Via Benzinga

Topics Intellectual Property

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma ↗

July 09, 2025

The takeover target just launched its first drug last summer. Shares have mostly trended higher since.

Via Investor's Business Daily

Topics Government

These stocks are moving in today's pre-market session ↗

July 09, 2025

As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 09, 2025

Via Benzinga

Merck To Acquire Verona For $10B In Bid To Expand Cardio-Pulmonary Pipeline ↗

July 09, 2025

Merck will acquire Verona for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion.

Via Stocktwits

Topics Government

Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

July 09, 2025

Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.

Via Benzinga

This Rollins Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

July 01, 2025

Via Benzinga

4 Health Care Stocks With Whale Alerts In Today's Session ↗

June 25, 2025

Via Benzinga

Oracle To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

June 18, 2025

Via Benzinga

Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today ↗

June 05, 2025

Via The Motley Fool

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data ↗

May 30, 2025

Regeneron and Sanofi's COPD drug itepekimab cut exacerbations by 27% in one Phase 3 trial, while the second trial did not meet its main goal.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.